Go Pro

Astera Labs (NASDAQ:ALAB) Stock Price Down 5.7% - Here's Why

Astera Labs logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Astera Labs shares fell 5.7% to $279.91, with trading volume about 37% below the average daily level. The stock remains highly valued, with a market capitalization of $48.56 billion and a P/E ratio of 138.57.
  • Analysts remain broadly positive, giving Astera Labs a consensus rating of “Moderate Buy” and an average price target of $340.53, although ratings range from “Strong Buy” to “Hold.”
  • The company recently exceeded quarterly expectations, reporting $0.80 in EPS and $392.4 million in revenue, up 104.5% year over year. However, insiders sold $163.1 million of shares during the last quarter, including substantial sales by a director and the COO.
  • MarketBeat previews the top five stocks to own by October 1st.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) shares fell 5.7% on Tuesday . The stock traded as low as $276.68 and last traded at $279.91. 3,385,477 shares changed hands during trading, a decline of 37% from the average daily volume of 5,336,723 shares. The stock had previously closed at $296.98.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the stock. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Astera Labs in a research note on Tuesday, August 18th. Morgan Stanley upped their price target on Astera Labs to $335.00 and gave the company an "overweight" rating in a research report on Monday, August 3rd. Citigroup reiterated a "buy" rating on shares of Astera Labs in a report on Wednesday, July 29th. Royal Bank Of Canada boosted their target price on shares of Astera Labs from $425.00 to $500.00 and gave the company an "outperform" rating in a report on Wednesday, August 5th. Finally, Barclays increased their price target on Astera Labs from $200.00 to $325.00 and gave the stock an "equal weight" rating in a report on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have issued a Hold rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $340.53.

View Our Latest Analysis on Astera Labs

Astera Labs Trading Down 5.7%

The company has a fifty day simple moving average of $339.53 and a two-hundred day simple moving average of $250.89. The company has a market cap of $48.56 billion, a PE ratio of 138.57 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same quarter in the prior year, the company posted $0.44 earnings per share. Astera Labs's revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Buying and Selling

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total value of $4,047,300.00. Following the transaction, the director directly owned 4,631 shares in the company, valued at approximately $2,083,950. This trade represents a 66.01% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of the business's stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief operating officer directly owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. The trade was a 7.49% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 419,244 shares of company stock valued at $163,135,169 in the last quarter. Corporate insiders own 10.40% of the company's stock.

Hedge Funds Weigh In On Astera Labs

Large investors have recently bought and sold shares of the company. Keating Financial Advisory Services Inc. acquired a new position in Astera Labs during the 2nd quarter worth approximately $25,000. Archer Investment Corp acquired a new position in Astera Labs during the second quarter worth $30,000. Transamerica Financial Advisors LLC purchased a new position in Astera Labs in the second quarter worth $35,000. Continuum Advisory LLC acquired a new stake in Astera Labs in the second quarter valued at $37,000. Finally, Johnson Financial Group Inc. acquired a new stake in Astera Labs in the second quarter valued at $43,000. Hedge funds and other institutional investors own 60.47% of the company's stock.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines